Search results
Results from the WOW.Com Content Network
The initial diagnosis was "peripheral neuropathy, cause of limb pain and redness to be determined". The lumbar puncture performed on the same day yielded normal results. The next day, a neurology consultation ruled out autoimmune diseases, poisoning, and metabolic diseases. PUMCH treated her according to the diagnosis of Guillain-Barré ...
Chronic, non-communicable diseases account for an estimated 80% of total deaths and 70% of disability-adjusted life years (DALYs) lost in China. Cardiovascular diseases, chronic respiratory disease, and cancer are the leading causes of both death and of the burden of disease, and exposure to risk factors is high: more than 300 million men smoke cigarettes and 160 million adults are ...
Chinese Center for Disease Control and Prevention (2019) ... Life expectancy and healthy life expectancy in China on the background of countries of Asia and Oceania ...
The infectious disease community is closely watching a surge of mystery illnesses in China that many have compared to the start of the COVID-19 outbreak. ... for Health Security, tells Yahoo Life ...
In 1994, Zhu was a second-year chemistry major and accomplished musician at Tsinghua, when she began to experience stomach pain, hair loss and other seemingly inexplicable symptoms that were later ...
[1] [2] Although China has made significant progress in improving public health and life expectancy, many challenges remain, including air pollution, food safety concerns, a growing burden of non-communicable diseases such as diabetes and cardiovascular disease, and an aging population.
While cardiomyopathy can be life-threatening, it is commonly resolved or substantially improved in Barth Syndrome patients after puberty. [ 10 ] Neutropenia , a granulocyte disorder that results in a low production of neutrophils, the body's primary defenders against bacterial infections, is another severe manifestation of Barth Syndrome.
Hirayama disease, also known as monomelic amyotrophy (MMA), [1] [2] is a rare motor neuron disease first described in 1959 in Japan. Its symptoms usually appear about two years after adolescent growth spurt and is significantly more common in males, with an average age of onset between 15 and 25 years.